BRTX
BioRestorative Therapies, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.69
+1.32%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.33x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.23x
- Price / sales
- 10.38x
- Price / cash flow
- -0.31x
Enterprise value
- Enterprise value
- $157.7K
- EV / sales
- 0.44x
- EV / EBITDA
- -0.01x
- EV / EBIT
- -0.01x
- Market cap
- $3.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026